Promius Pharma’s current portfolio contains innovative products for the treatment of seborrheic dermatitis, onychomycosis, acne, psoriasis and androgenic alopecia. Here are the product details:
Promiseb™ Topical Cream
Promiseb™ is contraindicated in persons with a known hypersensitivity to any component of the formulation. Please see accompanying important safety information and full prescribing info. For more info, visit www.Promiseb.com. Promiseb™ does not contain milk, wheat, peanut or animal derivatives. This Cream does contain shea butter (Butyrospermum parkii), a derivative of shea nut oil (not peanut oil). Patients with a known allergy to nuts or nut oils should consult their physician before using this topical preparation.
Scytera Foam is a novel coal tar foam for the treatment of psoriasis, a skin disease that affects approximately 7.5 million Americans according to the National Psoriasis Foundation. Scytera Foam delivers a time tested active ingredient, coal tar, in a cosmetically elegant foam formulation. Please visit www.scytera.com for more information about Scytera Foam, including usage instructions.
Cloderm Cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. The most common adverse events with Cloderm Cream include burning, itching, dryness, and folliculitis. Cloderm Cream is contraindicated in patients who are hypersensitive to any of the ingredients of this product. As with all topical corticosteroids, systemic absorption can produce reversible HPA-axis suppression.
Click here for more information on Cloderm Cream.